Tivic Health Systems (TIVC) versus The Competition Critical Analysis

StockNews.com assumed coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reiterated an overweight rating on shares of Zynerba Pharmaceuticals in a research note on Friday, March 31st. One research analyst has rated […]

Related Keywords

,Zynerba Pharmaceuticals ,Zynerba Pharmaceuticals Stock Down ,Renaissance Technologies ,Dimensional Fund Advisors ,Cantor Fitzgerald ,Hedge Funds Weigh In On Zynerba Pharmaceuticals ,Millennium Management ,Zynerba Pharmaceuticals Company Profile ,News Ratings For Zynerba Pharmaceuticals Daily ,Zynerba Pharmaceuticals Inc ,Vanguard Group Inc ,Get Rating ,Pharmaceuticals Stock Down ,Sigma Investments ,Fund Advisors ,Zynerba Pharmaceuticals Daily ,Nasdaq Zyne ,Zyne ,Medical ,Initiated Coverage ,Stocknews Com ,